These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1086 related articles for article (PubMed ID: 18819966)

  • 1. Has the licensing of respiratory quinolones for adults and the 7-valent pneumococcal conjugate vaccine (PCV-7) for children had herd effects with respect to antimicrobial non-susceptibility in invasive Streptococcus pneumoniae?
    Fenoll A; Aguilar L; Granizo JJ; Giménez MJ; Aragoneses-Fenoll L; Mendez C; Tarragó D
    J Antimicrob Chemother; 2008 Dec; 62(6):1430-3. PubMed ID: 18819966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased antimicrobial resistance among nonvaccine serotypes of Streptococcus pneumoniae in the pediatric population after the introduction of 7-valent pneumococcal vaccine in the United States.
    Farrell DJ; Klugman KP; Pichichero M
    Pediatr Infect Dis J; 2007 Feb; 26(2):123-8. PubMed ID: 17259873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changing epidemiology of antimicrobial-resistant Streptococcus pneumoniae in the United States, 2004-2005.
    Richter SS; Heilmann KP; Dohrn CL; Riahi F; Beekmann SE; Doern GV
    Clin Infect Dis; 2009 Feb; 48(3):e23-33. PubMed ID: 19115971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Epidemiological features of invasive pneumococcal disease before and after the introduction of pneumococcal conjugate vaccine in Gran Canaria (Canary Islands)].
    Artiles F; Horcajada I; Cañas AM; Alamo I; Bordes A; González A; Santana M; Lafarga B
    Enferm Infecc Microbiol Clin; 2009 Jan; 27(1):14-21. PubMed ID: 19217998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pneumococcal bacteraemia in Belgium (1994 2004): the pre-conjugate vaccine era.
    Flamaing J; Verhaegen J; Vandeven J; Verbiest N; Peetermans WE
    J Antimicrob Chemother; 2008 Jan; 61(1):143-9. PubMed ID: 17999974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of the pneumococcal conjugate vaccine on serotype distribution and antimicrobial resistance of invasive Streptococcus pneumoniae isolates in Dallas, TX, children from 1999 through 2005.
    Messina AF; Katz-Gaynor K; Barton T; Ahmad N; Ghaffar F; Rasko D; McCracken GH
    Pediatr Infect Dis J; 2007 Jun; 26(6):461-7. PubMed ID: 17529859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of antibiotic-resistant Streptococcus pneumoniae infections and the use of pneumococcal conjugate vaccines.
    Picazo JJ
    Clin Microbiol Infect; 2009 Apr; 15 Suppl 3():4-6. PubMed ID: 19366362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Streptococcus pneumoniae serotypes isolated from the middle ear fluid of Costa Rican children following introduction of the heptavalent pneumococcal conjugate vaccine into a limited population.
    Guevara S; Abdelnour A; Soley C; Porat N; Dagan R; Arguedas A
    Vaccine; 2012 Jun; 30(26):3857-61. PubMed ID: 22521846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serotype distribution and antimicrobial resistance of invasive and non-invasive pneumococccal isolates in Asturias, Spain.
    García-Suárez Mdel M; Villaverde R; Caldevilla AF; Méndez FJ; Vázquez F
    Jpn J Infect Dis; 2006 Oct; 59(5):299-05. PubMed ID: 17060695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nasopharyngeal carriage of Streptococcus pneumoniae in Gambian children who participated in a 9-valent pneumococcal conjugate vaccine trial and in their younger siblings.
    Cheung YB; Zaman SM; Nsekpong ED; Van Beneden CA; Adegbola RA; Greenwood B; Cutts FT
    Pediatr Infect Dis J; 2009 Nov; 28(11):990-5. PubMed ID: 19536041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serotypes and antimicrobial susceptibilities of 1033 pneumococci isolated from children in Greece during 2001-2004.
    Paraskakis I; Kafetzis DA; Chrisakis A; Papavasilliou H; Kirikou H; Pangalis A; Tzouvelekis LS; Athanasiou T; Legakis NJ;
    Clin Microbiol Infect; 2006 May; 12(5):490-3. PubMed ID: 16643530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Invasive Streptococcus pneumoniae from Portugal: implications for vaccination and antimicrobial therapy.
    Serrano I; Ramirez M; Melo-Cristino J;
    Clin Microbiol Infect; 2004 Jul; 10(7):652-6. PubMed ID: 15214879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variations in serotypes and susceptibility of adult non-invasive Streptococcus pneumoniae isolates between the periods before (May 2000-May 2001) and 10 years after (May 2010-May 2011) introduction of conjugate vaccines for child immunisation in Spain.
    Fenoll A; Aguilar L; Giménez MJ; Vicioso MD; Robledo O; Granizo JJ; Coronel P
    Int J Antimicrob Agents; 2012 Jul; 40(1):18-23. PubMed ID: 22578763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emergence of Streptococcus pneumoniae serotypes 19A, 6C, and 22F and serogroup 15 in Cleveland, Ohio, in relation to introduction of the protein-conjugated pneumococcal vaccine.
    Jacobs MR; Good CE; Bajaksouzian S; Windau AR
    Clin Infect Dis; 2008 Dec; 47(11):1388-95. PubMed ID: 18959493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serotype coverage of pneumococcal conjugate vaccine and drug susceptibility of Streptococcus pneumoniae isolated from invasive or non-invasive diseases in central Thailand, 2006-2009.
    Srifeungfung S; Tribuddharat C; Comerungsee S; Chatsuwan T; Treerauthanaweeraphong V; Rungnobhakhun P; Nunthapisud P; Chokephaibulkit K
    Vaccine; 2010 Apr; 28(19):3440-4. PubMed ID: 20199759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduction in high rates of antibiotic-nonsusceptible invasive pneumococcal disease in tennessee after introduction of the pneumococcal conjugate vaccine.
    Talbot TR; Poehling KA; Hartert TV; Arbogast PG; Halasa NB; Mitchel E; Schaffner W; Craig AS; Edwards KM; Griffin MR
    Clin Infect Dis; 2004 Sep; 39(5):641-8. PubMed ID: 15356776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in the Serotype Distribution among Antibiotic Resistant Carriage Streptococcus pneumoniae Isolates in Children after the Introduction of the Extended-Valency Pneumococcal Conjugate Vaccine.
    Lee JK; Yun KW; Choi EH; Kim SJ; Lee SY; Lee HJ
    J Korean Med Sci; 2017 Sep; 32(9):1431-1439. PubMed ID: 28776337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serotype and antimicrobial susceptibility patterns of isolates of Streptococcus pneumoniae causing invasive disease in The Gambia 1996-2003.
    Adegbola RA; Hill PC; Secka O; Ikumapayi UN; Lahai G; Greenwood BM; Corrah T
    Trop Med Int Health; 2006 Jul; 11(7):1128-35. PubMed ID: 16827713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serotypes and antimicrobial susceptibilities of invasive Streptococcus pneumoniae pre- and post-seven valent pneumococcal conjugate vaccine introduction in Alberta, Canada, 2000-2006.
    Tyrrell GJ; Lovgren M; Chui N; Minion J; Garg S; Kellner JD; Marrie TJ
    Vaccine; 2009 Jun; 27(27):3553-60. PubMed ID: 19464534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibiotic susceptibility and molecular epidemiology of nasopharyngeal pneumococci from Spanish children.
    Sánchez-Tatay D; Arroyo LA; Tarragó D; Lirola MJ; Porras A; Fenoll A; Hausdorff WP; Brueggemann AB; Obando I
    Clin Microbiol Infect; 2008 Aug; 14(8):797-801. PubMed ID: 18727804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 55.